62570 Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and CMX intends 

to file additional written notifications 

disclosing all changes in membership. 

On March 12, 2010, CMX filed its 

original notification pursuant to Section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on April 16, 2010 (75 FR 20003). 

The last notification was filed with 

the Department on May 28, 2010. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on July 14, 2010 (75 FR 40851). 

Patricia A. Brink, 

Deputy Director of Operations, Antitrust 

Division. 

[FR Doc. 2010–25212 Filed 10–8–10; 8:45 am] 

BILLING CODE 4410–11–M 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Marine Well Containment 

Venture 

Notice is hereby given that, on August 

18, 2010, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Marine Well 

Containment Venture (‘‘MWCV’’) has 

filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing (1) the identities 

and nationalities of the parties to the 

production venture and any person who 

controls a party to the venture and (2) 

the nature and objectives of the venture. 

The notifications were filed for the 

purpose of invoking the Act’s provisions 

limiting the recovery of antitrust 

plaintiffs to actual damages under 

specified circumstances. 

Pursuant to Section 6(b) of the Act, 

the identities of the parties to the 

venture are: Chevron USA, Inc., 

Houston, TX; ConocoPhillips Co., 

Houston, TX; ExxonMobil Development 

Co., Houston, TX; and Shell Offshore 

Inc., Houston, TX. The general area of 

MWCV’s planned activity is (i) to 

design, produce (assemble and/or 

construct), operate, maintain, and own a 

system to provide emergency 

hydrocarbon well containment and 

related non-emergency services in the 

Gulf of Mexico and potentially in other 

regions; and (ii) to perform and sponsor 

related research and development 

activities. 

Patricia A. Brink, 

Deputy Director of Operations, Antitrust 

Division. 

[FR Doc. 2010–25206 Filed 10–8–10; 8:45 am] 

BILLING CODE 4410–11–M 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated March 10, 2008, and 

published in the Federal Register on 

March 19, 2008 (73 FR 14841), Chemica, 

Inc., 316 West 130th Street, Los 

Angeles, California 90061, made 

application by letter to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

methamphetamine (1105), a basic class 

of controlled substance listed in 

schedule II. 

The above-listed controlled substance 

is an intermediate in the manufacture of 

Benzphetamine, a schedule III nonnarcotic controlled substance. The 

methamphetamine will not be sold as a 

commercial product in the domestic 

market. 

A comment and objection was 

received. However, after a thorough 

review of this matter, DEA has 

concluded that issues raised in the 

comment and objection do not warrant 

the denial of this application. 

DEA has considered the factors in 21 

U.S.C. 823(a) and determined that the 

registration of Chemica, Inc. to 

manufacture the listed basic class of 

controlled substance is consistent with 

the public interest at this time. DEA has 

investigated Chemica, Inc. to ensure that 

the company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic class of controlled substance 

listed. 

Dated: October 5, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–25540 Filed 10–8–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated June 17, 2010, and 

published in the Federal Register on 

June 28, 2010 (75 FR 36683), Siegfried 

(USA), 33 Industrial Park Road, 

Pennsville, New Jersey 08070, made 

application by letter to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

Gamma Hydroxybutyric Acid (2010), a 

basic class of controlled substance listed 

in schedule I. 

The company plans to manufacture 

the listed controlled substance in bulk 

for sale to customers. 

Three comments were received. Two 

of the three comments supported the 

granting of registration as a bulk 

manufacturer of the basic class of 

controlled substance listed to this 

applicant. 

The third comment objected to the 

granting of registration. However, after a 

thorough review of this matter, DEA has 

concluded that the issues raised in the 

comment and objection do not warrant 

the denial of this application. 

DEA has considered the factors in 21 

U.S.C. 823(a) and determined that the 

registration of Siegfried (USA) to 

manufacture the listed basic class of 

controlled substance is consistent with 

the public interest at this time. DEA has 

investigated Siegfried (USA) to ensure 

that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic class of controlled substance 

listed. 

Dated: October 5, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–25539 Filed 10–8–10; 8:45 am] 

BILLING CODE 4410–09–P 


srobinson on DSKHWCL6B1PROD with NOTICES